Agilent Technologies, Inc.: Form 10-Q for the period ended Apr 30, 2017
Filed with the SEC on Jun 6, 2017 and accepted by EDGAR at Jun 6, 2017, 16:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-04-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2017-02-01 to 2017-04-30 | $1.10bn | us-gaap:SalesRevenueNet |
| Revenue | 6 months2016-11-01 to 2017-04-30 | $2.17bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2017-02-01 to 2017-04-30 | $510.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2016-11-01 to 2017-04-30 | $1.00bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2017-02-01 to 2017-04-30 | $84.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2016-11-01 to 2017-04-30 | $163.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2017-02-01 to 2017-04-30 | $307.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2016-11-01 to 2017-04-30 | $596.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-02-01 to 2017-04-30 | $201.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2016-11-01 to 2017-04-30 | $407.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-02-01 to 2017-04-30 | $20.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2016-11-01 to 2017-04-30 | $40.0m | us-gaap:InterestExpense |
| Income tax | 3 months2017-02-01 to 2017-04-30 | $27.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2016-11-01 to 2017-04-30 | $52.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-02-01 to 2017-04-30 | $164.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2016-11-01 to 2017-04-30 | $332.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-02-01 to 2017-04-30 | $0.50 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2016-11-01 to 2017-04-30 | $1.02 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-02-01 to 2017-04-30 | $0.51 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2016-11-01 to 2017-04-30 | $1.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-02-01 to 2017-04-30 | 325,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2016-11-01 to 2017-04-30 | 325,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2016-11-01 to 2017-04-30 | $373.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2016-11-01 to 2017-04-30 | $75.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2017-02-01 to 2017-04-30 | $43.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 6 months2016-11-01 to 2017-04-30 | $85.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2016-11-01 to 2017-04-30 | $194.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-04-30 | $2.39bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-04-30 | $3.80bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-04-30 | $8.02bn | us-gaap:Assets |
| Current liabilities | At period end2017-04-30 | $1.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-04-30 | $3.64bn | us-gaap:Liabilities |
| Long-term debt | At period end2017-04-30 | $1.80bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2017-04-30 | $241.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-04-30 | $4.37bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001090872-17-000008. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.